Krensavage Asset Management, LLC

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1609251 NEW YORK, NY

Back to INDV Full portfolio

Position in INDV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,348,935

New position

Shares Held

339,532

first reported quarter

Ownership

0.278%

of shares outstanding

% of Portfolio

4.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $79,296,778 across 5 Drug Manufacturers - Specialty & Generic names. INDV ranks #3 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	84,282	$49,977,540
2	SUPN	Supernus Pharmaceuticals, Inc.	280,681	$14,508,400
3	INDV	Indivior Pharmaceuticals, Inc. This page	339,532	$10,348,935
4	ALKS	Alkermes plc.	107,822	$3,812,585
5	EOLS	Evolus, Inc.	157,985	$649,318

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,348,935	339,532	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.

Krensavage Asset Management, LLC

Position in INDV

Position in Drug Manufacturers - Specialty & Generic

All Filings in INDV